著作(論文等)

基本情報

氏名 小島 肇
氏名(カナ) コジマ ハジメ
氏名(英語) KOJIMA Hajime
所属 山陽小野田市立山口東京理科大学工学部医薬工学科
職名 教授
researchmap研究者コード
researchmap機関

発表形態

掲載年月

2025/08

掲載誌名等

The Journal of Toxicological Sciences

著者名

1. Mori K, Aoki Y, Hayashi M, Sugimoto W, Ono M, Umekita S, Niino T, Ebata T, Mikashima F, Maki K, Tanaka T, Hirata H, Kojima H.

50

8

開始頁

431

 

終了頁

444

出版者(日本語)

一般社団法人 日本毒性学会

出版者(英語)

The Japanese Society of Toxicology

概要

Exposure of embryos or fetuses to harmful substances, such as teratogens, can result in embryonic or fetal death and a wide range of malformations. Zebrafish models have emerged as a valuable tool for assessing developmental toxicity and safety profiles of chemical compounds. Our previous research demonstrated that zebrafish larvae exhibit developmental abnormalities that mirror those observed in mammalian studies for more than 80% of the known Reference Compounds listed in the ICH S5 (R3) guideline. In this study, we presented high-resolution images depicting pharmaceutical-induced malformations across multiple anatomical regions, including the body axis, somites, notochord, fins, head, eyes, otoliths, jaw, heart, abdomen, and whole body. Frequent co-occurrence of specific defects, such as body axis and notochord malformations, was observed as described previously. Some physiological and morphological features, including heartbeat rate alterations and swim bladder inflation, were deemed dispensable for MEFL testing in zebrafish. Reproducibility was confirmed through inter-laboratory testing conducted both within our group and by other groups, supporting the reliability of zebrafish MEFL testing as an alternative approach in line with ICH S5 (R3).